Stryker Corporation (TSX:SYK)
Canada · Delayed Price · Currency is CAD 21.43
-0.38 (-1.74%)
Nov 11, 2026, 4:00 PM EST
Stryker Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 26,300 | 25,116 | 22,595 | 20,498 | 18,449 | 17,108 |
Revenue Growth | 7.87% | 11.16% | 10.23% | 11.11% | 7.84% | 19.21% |
Gross Profit Gross Profit Growth | 17,279 | 16,336 | 14,545 | 13,097 | 11,646 | 11,262 |
Operating Income Operating Income Growth | 6,303 | 5,756 | 4,956 | 4,114 | 3,553 | 3,656 |
Net Income Net Income Growth | 3,623 | 3,246 | 2,993 | 3,165 | 2,358 | 1,994 |
Earnings Per Share EPS Growth | 9.39 | 8.40 | 7.76 | 8.25 | 6.17 | 5.21 |
EPS Growth | 23.36% | 8.25% | -5.94% | 33.71% | 18.43% | 24.05% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Instruments Instruments Growth | - | 3,183 | 2,834 | 2,534 | 2,279 | 2,111 |
Endoscopy Endoscopy Growth | 4,038 | 3,807 | 3,389 | 3,068 | 2,725 | 2,418 |
Medical Medical Growth | 4,389 | 4,204 | 3,852 | 3,459 | 3,031 | 2,607 |
Neurovascular Neurovascular Growth | 2,118 | 1,968 | 1,307 | 1,226 | 1,200 | 1,188 |
Neuro Cranial Neuro Cranial Growth | - | 2,485 | 2,136 | 1,876 | 1,376 | 1,214 |
Knees Knees Growth | 2,747 | 2,656 | 2,447 | 2,273 | 1,997 | 1,848 |
Hips Hips Growth | 1,891 | 1,865 | 1,704 | 1,544 | 1,413 | 1,342 |
Trauma and Extremities Trauma and Extremities Growth | 4,203 | 3,948 | 3,507 | 3,147 | 2,807 | 2,664 |
Spinal Implants Spinal Implants Growth | 17 | 185 | 707 | 713 | 1,146 | 1,167 |
Other Orthopaedics Other Orthopaedics Growth | - | 815 | 712 | 658 | 475 | 549 |
Revenue (Total) Revenue (Total) Growth | 26,300 | 25,116 | 22,595 | 20,498 | 18,449 | 17,108 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,271 | 4,100 | 4,493 | 3,053 | 1,928 | 3,019 |
Total Debt Total Debt Growth | 15,433 | 16,360 | 14,120 | 13,494 | 13,526 | 12,901 |
Net Cash (Debt) Net Cash Growth | -12,162 | -12,260 | -9,627 | -10,441 | -11,598 | -9,882 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -31.51 | -31.72 | -24.97 | -27.21 | -30.35 | -25.85 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,446 | 5,044 | 4,242 | 3,711 | 2,624 | 3,263 |
Capital Expenditures CapEx Growth | -873 | -761 | -755 | -575 | -588 | -525 |
Free Cash Flow Free Cash Flow Growth | 4,573 | 4,283 | 3,487 | 3,136 | 2,036 | 2,738 |
Free Cash Flow Growth | 12.28% | 22.83% | 11.19% | 54.03% | -25.64% | -1.86% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.70% | 65.04% | 64.37% | 63.89% | 63.13% | 65.83% |
Operating Margin | 23.97% | 22.92% | 21.93% | 20.07% | 19.26% | 21.37% |
Pretax Margin | 19.45% | 17.97% | 15.45% | 17.92% | 14.54% | 13.33% |
Profit Margin | 13.78% | 12.92% | 13.25% | 15.44% | 12.78% | 11.65% |
FCF Margin | 17.39% | 17.05% | 15.43% | 15.30% | 11.04% | 16.00% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.117 | 3.400 | 3.240 | 3.050 | 2.835 | 2.585 |
Dividend Per Share Growth | 0% | 4.94% | 6.23% | 7.58% | 9.67% | 9.77% |
Dividend Yield | 0.55% | 0.97% | 0.90% | 1.02% | 1.16% | 0.97% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.94 | 41.41 | 45.86 | 35.95 | 39.24 | 50.59 |
P/FCF Ratio | 26.48 | 31.38 | 39.36 | 36.28 | 45.44 | 36.85 |
PS Ratio | 4.60 | 5.35 | 6.08 | 5.55 | 5.01 | 5.90 |